Published in J Clin Invest on March 24, 2010
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature (2014) 4.00
Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res (2012) 2.51
Embryonic stem cell-derived cardiac myocytes are not ready for human trials. Circ Res (2014) 2.21
Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell (2013) 1.86
Induced pluripotent stem cells: developmental biology to regenerative medicine. Nat Rev Cardiol (2010) 1.71
Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science (2014) 1.49
Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res (2015) 1.46
Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 1.31
Regeneration of the heart. EMBO Mol Med (2011) 1.27
Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions. Cell Res (2013) 1.26
Early cardiac development: a view from stem cells to embryos. Cardiovasc Res (2012) 1.18
Cardiac differentiation of pluripotent stem cells. Stem Cells Int (2011) 1.09
Functional cardiac tissue engineering. Regen Med (2012) 1.07
BAF60 A, B, and Cs of muscle determination and renewal. Genes Dev (2012) 1.01
Pluripotent stem cell models of human heart disease. Cold Spring Harb Perspect Med (2013) 1.01
Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues. PLoS One (2013) 1.00
Current status of drug screening and disease modelling in human pluripotent stem cells. Bioessays (2012) 0.98
Epigenetic factors and cardiac development. Cardiovasc Res (2011) 0.97
Coordinate Nodal and BMP inhibition directs Baf60c-dependent cardiomyocyte commitment. Genes Dev (2013) 0.96
Characterization of single-nucleotide variation in Indian-origin rhesus macaques (Macaca mulatta). BMC Genomics (2011) 0.96
Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease. Clin Sci (Lond) (2013) 0.95
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther (2014) 0.95
Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. PLoS One (2012) 0.95
Progress and prospects for genetic modification of nonhuman primate models in biomedical research. ILAR J (2013) 0.93
Programming and reprogramming a human heart cell. EMBO J (2015) 0.92
Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. Eur Heart J (2016) 0.91
Intramyocardial Injection of Pig Pluripotent Stem Cells Improves Left Ventricular Function and Perfusion: A Study in a Porcine Model of Acute Myocardial Infarction. PLoS One (2013) 0.91
Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells. Mol Ther (2012) 0.90
Human pluripotent stem cells for modelling human liver diseases and cell therapy. Curr Gene Ther (2013) 0.90
Regenerative medicine for the heart: perspectives on stem-cell therapy. Antioxid Redox Signal (2014) 0.87
Model systems for cardiovascular regenerative biology. Cold Spring Harb Perspect Med (2013) 0.87
Cardiac regeneration using pluripotent stem cells--progression to large animal models. Stem Cell Res (2014) 0.86
Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction. PLoS One (2014) 0.85
Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction. J Cell Mol Med (2013) 0.85
Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Adv Drug Deliv Rev (2015) 0.83
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv Drug Deliv Rev (2015) 0.83
Isoflurane decreases death of human embryonic stem cell-derived, transcriptional marker Nkx2.5(+) cardiac progenitor cells. Acta Anaesthesiol Scand (2011) 0.83
Induced pluripotent stem cells in cardiovascular medicine. Stem Cells Int (2011) 0.83
Immune response to human embryonic stem cell-derived cardiac progenitors and adipose-derived stromal cells. J Cell Mol Med (2012) 0.83
Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. Biomed Res Int (2014) 0.83
Genetic networks governing heart development. Cold Spring Harb Perspect Med (2014) 0.83
Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine. Annu Rev Genet (2015) 0.82
Pluripotent stem cell derived cardiomyocytes for cardiac repair. Curr Treat Options Cardiovasc Med (2014) 0.82
Pluripotent stem cells for cardiac regeneration: overview of recent advances & emerging trends. Indian J Med Res (2013) 0.82
SWI/SNF in cardiac progenitor cell differentiation. J Cell Biochem (2013) 0.81
Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector. Hum Gene Ther Methods (2013) 0.81
Epigenetic regulation of the electrophysiological phenotype of human embryonic stem cell-derived ventricular cardiomyocytes: insights for driven maturation and hypertrophic growth. Stem Cells Dev (2013) 0.81
Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems. Int J Mol Sci (2016) 0.80
Integration-deficient lentivectors: an effective strategy to purify and differentiate human embryonic stem cell-derived hepatic progenitors. BMC Biol (2013) 0.80
Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives. Stem Cell Res Ther (2013) 0.80
Marching towards regenerative cardiac therapy with human pluripotent stem cells. Discov Med (2013) 0.80
Cellular retrograde cardiomyoplasty and relaxin therapy for postischemic myocardial repair in a rat model. Tex Heart Inst J (2012) 0.79
Transient Mesp1 expression: a driver of cardiac cell fate determination. Transcription (2013) 0.79
Pluripotent Stem Cell Therapy in Ischemic Cardiovascular Disease. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 0.79
Myocardial restoration: is it the cell or the architecture or both? Cardiol Res Pract (2012) 0.79
Mitochondrial Ca(2+) uptake by the voltage-dependent anion channel 2 regulates cardiac rhythmicity. Elife (2015) 0.79
Magnetic Resonance Imaging of Iron Oxide-Labeled Human Embryonic Stem Cell-Derived Cardiac Progenitors. Stem Cells Transl Med (2015) 0.78
Monkeying around with cardiac progenitors: hope for the future. J Clin Invest (2010) 0.78
Activin-A and Bmp4 levels modulate cell type specification during CHIR-induced cardiomyogenesis. PLoS One (2015) 0.78
A cohesin-OCT4 complex mediates Sox enhancers to prime an early embryonic lineage. Nat Commun (2015) 0.78
Methods of cell purification: a critical juncture for laboratory research and translational science. Cells Tissues Organs (2011) 0.78
ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarction. JCI Insight (2016) 0.77
Myoblasts and embryonic stem cells differentially engraft in a mouse model of genetic dilated cardiomyopathy. Mol Ther (2013) 0.77
Bone marrow SSEA1+ cells support the myocardium in cardiac pressure overload. PLoS One (2013) 0.77
CD13 and ROR2 Permit Isolation of Highly Enriched Cardiac Mesoderm from Differentiating Human Embryonic Stem Cells. Stem Cell Reports (2016) 0.77
Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming. Stem Cells Transl Med (2014) 0.77
Cardiac Repair and Regeneration: The Value of Cell Therapies. Eur Cardiol (2015) 0.76
Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases. Circ Res (2017) 0.75
What your heart doth know. Cell Stem Cell (2011) 0.75
Heart Regeneration with Embryonic Cardiac Progenitor Cells and Cardiac Tissue Engineering. J Stem Cell Transplant Biol (2015) 0.75
Cryopreservation of Human Pluripotent Stem Cell-Derived Cardiomyocytes: Strategies, Challenges, and Future Directions. Adv Exp Med Biol (2016) 0.75
Mesp1 Marked Cardiac Progenitor Cells Repair Infarcted Mouse Hearts. Sci Rep (2016) 0.75
Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation. Arch Immunol Ther Exp (Warsz) (2016) 0.75
De novo myocardial regeneration: advances and pitfalls. Antioxid Redox Signal (2010) 0.75
GCNF-dependent activation of cyclin D1 expression via repression of Mir302a during ESC differentiation. Stem Cells (2014) 0.75
Wnt/β-Catenin Stimulation and Laminins Support Cardiovascular Cell Progenitor Expansion from Human Fetal Cardiac Mesenchymal Stromal Cells. Stem Cell Reports (2016) 0.75
Coupling switch of P2Y-IP3 receptors mediates differential Ca(2+) signaling in human embryonic stem cells and derived cardiovascular progenitor cells. Purinergic Signal (2016) 0.75
Can stem cells really regenerate the human heart? Use your noggin, dickkopf! Lessons from developmental biology. Cardiovasc J Afr (2013) 0.75
Direct myocardial implantation of human embryonic stem cells in a dog model of Duchenne cardiomyopathy reveals poor cell survival in dystrophic tissue. J Stem Cells Regen Med (2011) 0.75
Enhanced Human-Induced Pluripotent Stem Cell Derived Cardiomyocyte Maturation Using a Dual Microgradient Substrate. ACS Biomater Sci Eng (2016) 0.75
Simulated Microgravity and 3D Culture Enhance Induction, Viability, Proliferation and Differentiation of Cardiac Progenitors from Human Pluripotent Stem Cells. Sci Rep (2016) 0.75
CITED2 Cooperates with ISL1 and Promotes Cardiac Differentiation of Mouse Embryonic Stem Cells. Stem Cell Reports (2016) 0.75
Knockdown of the cell cycle inhibitor p21 enhances cartilage formation by induced pluripotent stem cells. Tissue Eng Part A (2015) 0.75
Myocardial Tissue Engineering for Regenerative Applications. Curr Cardiol Rep (2017) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80
Core transcriptional regulatory circuitry in human embryonic stem cells. Cell (2005) 34.93
Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell (2008) 16.38
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol (2007) 14.48
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell (2008) 12.29
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature (2008) 10.27
Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res (2008) 10.18
Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell (2003) 8.00
Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med (2006) 7.21
Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell (2006) 7.21
Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat Cell Biol (2007) 6.30
Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc (2006) 6.24
Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell (2006) 6.19
A myocardial lineage derives from Tbx18 epicardial cells. Nature (2008) 6.15
A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell (2008) 5.99
MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell (2008) 4.70
Stem-cell-based therapy and lessons from the heart. Nature (2008) 4.54
Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol (2008) 4.07
Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol (2007) 4.05
Conotruncal myocardium arises from a secondary heart field. Development (2001) 3.64
Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis. Proc Natl Acad Sci U S A (2006) 3.54
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation (2008) 3.30
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci U S A (2008) 3.13
Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell (2008) 3.07
The miR-430/427/302 family controls mesendodermal fate specification via species-specific target selection. Dev Cell (2009) 3.01
Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development (2002) 2.59
Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells (2002) 2.50
Identification of cardiac-specific myosin light chain kinase. Circ Res (2008) 2.45
Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res (2008) 2.31
Cardiac stem cells in the real world. J Thorac Cardiovasc Surg (2008) 2.19
Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling. Development (2008) 2.14
Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells. Stem Cells (2007) 2.10
The clonal origin of myocardial cells in different regions of the embryonic mouse heart. Dev Cell (2004) 2.00
Spatial and temporal patterns of c-kit-expressing cells in WlacZ/+ and WlacZ/WlacZ mouse embryos. Development (1996) 1.95
Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J Cell Biol (2005) 1.93
BMP receptor IA is required in mammalian neural crest cells for development of the cardiac outflow tract and ventricular myocardium. Development (2004) 1.93
Reassessment of Isl1 and Nkx2-5 cardiac fate maps using a Gata4-based reporter of Cre activity. Dev Biol (2008) 1.88
Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation (2006) 1.75
Foxh1 is essential for development of the anterior heart field. Dev Cell (2004) 1.74
Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. J Immunol (1999) 1.62
Dedifferentiation of atrial myocytes during atrial fibrillation: role of fibroblast proliferation in vitro. Cardiovasc Res (2002) 1.62
A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart. J Clin Invest (2007) 1.61
A common progenitor at the heart of development. Cell (2006) 1.56
Retinoic acid deficiency alters second heart field formation. Proc Natl Acad Sci U S A (2008) 1.51
Generation of multipotential mesendodermal progenitors from mouse embryonic stem cells via sustained Wnt pathway activation. J Biol Chem (2007) 1.45
Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev Cell (2006) 1.44
Identification of downstream genetic pathways of Tbx1 in the second heart field. Dev Biol (2008) 1.39
Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. J Cell Biol (2009) 1.28
Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells (2007) 1.24
Cardiac neural crest expression of Hand2 regulates outflow and second heart field development. Circ Res (2008) 1.19
Gene expression profiling of the forming atrioventricular node using a novel tbx3-based node-specific transgenic reporter. Circ Res (2009) 1.18
Cardiac commitment of primate embryonic stem cells. Nat Protoc (2008) 1.12
Cooperation between the activin and Wnt pathways in the spatial control of organizer gene expression. Proc Natl Acad Sci U S A (1998) 1.11
Left and right ventricular contributions to the formation of the interventricular septum in the mouse heart. Dev Biol (2006) 1.08
Hes1 is expressed in the second heart field and is required for outflow tract development. PLoS One (2009) 1.01
An evolutionarily conserved nuclear export signal facilitates cytoplasmic localization of the Tbx5 transcription factor. Mol Cell Biol (2007) 0.96
Oct-3/4: not just a gatekeeper of pluripotency for embryonic stem cell, a cell fate instructor through a gene dosage effect. Cell Cycle (2007) 0.96
Spatio-temporal intersection of Lhx3 and Tbx6 defines the cardiac field through synergistic activation of Mesp. Dev Biol (2009) 0.92
Prospective areas and differentiation potencies in chick blastoderm. Ann N Y Acad Sci (1948) 0.79
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54
Disease-specific induced pluripotent stem cells. Cell (2008) 16.95
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18
Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med (2005) 12.64
A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell (2008) 5.99
Human embryonic stem cells derived by somatic cell nuclear transfer. Cell (2013) 5.91
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation (2003) 5.85
Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol (2011) 5.63
Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res (2011) 5.30
Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science (2007) 5.07
Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature (2009) 4.98
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol (2003) 4.91
Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet (2012) 4.85
Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med (2005) 4.85
GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell (2007) 4.22
In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol (2009) 3.97
Towards germline gene therapy of inherited mitochondrial diseases. Nature (2012) 3.73
Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet (2006) 3.65
A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet (2011) 3.59
Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity (2013) 3.50
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation (2008) 3.30
PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. J Clin Invest (2012) 2.61
Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res (2006) 2.56
Stem cell differentiation requires a paracrine pathway in the heart. FASEB J (2002) 2.55
Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat. J Am Coll Cardiol (2003) 2.53
Rapid mitochondrial DNA segregation in primate preimplantation embryos precedes somatic and germline bottleneck. Cell Rep (2012) 2.50
PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res (2012) 2.43
Generation of chimeric rhesus monkeys. Cell (2012) 2.41
Coordination of intratumoral immune reaction and human colorectal cancer recurrence. Cancer Res (2009) 2.37
Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet (2005) 2.36
Optimal timing of inner cell mass isolation increases the efficiency of human embryonic stem cell derivation and allows generation of sibling cell lines. Cell Stem Cell (2009) 2.31
Cell-based cardiac repair: reflections at the 10-year point. Circulation (2005) 2.25
Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas. Am J Surg Pathol (2014) 2.23
Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int (2010) 2.22
Cardiac stem cells in the real world. J Thorac Cardiovasc Surg (2008) 2.19
Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med (2010) 2.15
Control of vertebrate multiciliogenesis by miR-449 through direct repression of the Delta/Notch pathway. Nat Cell Biol (2011) 2.09
Can erythropoietin improve skeletal myoblast engraftment in infarcted myocardium? Interact Cardiovasc Thorac Surg (2007) 2.07
Tracheal regeneration: evidence of bone marrow mesenchymal stem cell involvement. J Thorac Cardiovasc Surg (2012) 2.07
Sports-related sudden death in the general population. Circulation (2011) 2.06
Relation of heart rate at rest and long-term (>20 years) death rate in initially healthy middle-aged men. Am J Cardiol (2008) 2.03
Deep hypothermia and low flow for surgery for abdominal or extraperitoneal tumors with cavoatrial extension. Ann Thorac Surg (2013) 2.01
Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology (2009) 2.01
Spermatogonial stem cell transplantation into rhesus testes regenerates spermatogenesis producing functional sperm. Cell Stem Cell (2012) 1.99
Alveolar epithelial type I cells contain transport proteins and transport sodium, supporting an active role for type I cells in regulation of lung liquid homeostasis. Proc Natl Acad Sci U S A (2002) 1.95
KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet (2012) 1.93
High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clin J Am Soc Nephrol (2007) 1.90
An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes. Nucleic Acids Res (2006) 1.87
GFP expression in muscle cells impairs actin-myosin interactions: implications for cell therapy. Nat Methods (2006) 1.83
Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol (2007) 1.81
Rewirable gene regulatory networks in the preimplantation embryonic development of three mammalian species. Genome Res (2010) 1.81
High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med (2003) 1.80
Parietal podocytes in normal human glomeruli. J Am Soc Nephrol (2006) 1.79
Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol (2004) 1.79
Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann Thorac Surg (2009) 1.76
Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib. Nephrol Dial Transplant (2008) 1.76
Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol (2004) 1.73
Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs. Cell Stem Cell (2012) 1.72
Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT. J Heart Lung Transplant (2013) 1.71
Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res (2006) 1.71
Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One (2009) 1.70
Comprehensive annular and subvalvular repair of chronic ischemic mitral regurgitation improves long-term results with the least ventricular remodeling. Circulation (2012) 1.68
Cell cycle features of primate embryonic stem cells. Stem Cells (2005) 1.64
Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation (2006) 1.63
Excessive heart rate increase during mild mental stress in preparation for exercise predicts sudden death in the general population. Eur Heart J (2009) 1.61
Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillation. Eur Heart J (2008) 1.55
Tracheal replacement with cryopreserved, decellularized, or glutaraldehyde-treated aortic allografts. Ann Thorac Surg (2009) 1.55
Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies. Kidney Int (2010) 1.54
Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. Eur Heart J (2008) 1.54
Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol (2011) 1.53
miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLoS Genet (2013) 1.53
Evidence of leaflet injury during percutaneous aortic valve deployment. Eur J Cardiothorac Surg (2010) 1.52
A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy. J Am Soc Nephrol (2011) 1.51
Mapping myocardial fiber orientation using echocardiography-based shear wave imaging. IEEE Trans Med Imaging (2011) 1.49
Quantitative assessment of arterial wall biomechanical properties using shear wave imaging. Ultrasound Med Biol (2010) 1.49
Chromosome transfer in mature oocytes. Nat Protoc (2010) 1.48
Expression of heart K+ channels in adrenalectomized and catecholamine-depleted reserpine-treated rats. J Mol Cell Cardiol (2003) 1.47
Gene polymorphisms and cytokine plasma levels as predictive factors of complications after cardiopulmonary bypass. J Thorac Cardiovasc Surg (2012) 1.47
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood (2002) 1.46